ERC-SG-LS7
ERC-SG-LS7
Programme: H2020
106 projects · €153,161,413 total EU contribution (project-level) · 97 participating organizations · 17 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€153,161,413
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (14)
- Germany (13)
- Netherlands (11)
- Spain (10)
- Italy (9)
- IL (6)
- CH (5)
- DK (5)
- France (5)
- BE (4)
- SE (4)
- EL (3)
- FI (3)
- EE (1)
- HU (1)
- IE (1)
- PT (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5 projects · UK
- UNIVERSITY COLLEGE LONDON4 projects · —
- AU3 projects · DK
- EPFL3 projects · CH
- FONDAZIONE TELETHON ETS3 projects · IT
- HELSINGIN YLIOPISTO3 projects · FI
- INSERM3 projects · FR
- BGU2 projects · IL
- CEA2 projects · FR
- ETH Zürich2 projects · CH
- HMGU2 projects · DE
- IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2 projects · UK
Projects
Page 4 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Development of 3D Histopathological Grading of Osteoarthritis 3D-OA-HISTO · 336267 | FP7 | €1,500,000 | €1,500,000 | Details |
Exploring the human brain using magnetic resonance imaging and parallel transmission at ultra-high field EXPAT · 309674 | FP7 | €1,499,292 | €1,499,292 | Details |
Repair Spinal Cord Injury by Controlling Migration of Neural Stem Cells - multidiciplinary approaches of electric stimulation and nanotechnology SCINSCEF · 243261 | FP7 | €1,759,613 | €1,759,613 | Details |
DNA binding proteins for treatment of gain of function mutations ALLELECHOKER · 311682 | FP7 | €1,354,840 | €1,354,840 | Details |
Oncolytic adenoviruses expressing monoclonal antibody trastuzumab for treatment of Her-2+ cancer TRASTUZUCRAD · 201667 | FP7 | €1,622,360 | €1,622,360 | Details |
Enrichment of macular pigment, and its impact on vision and blindness CREST · 281096 | FP7 | €1,493,342 | €1,493,342 | Details |
Role of the transcription factor Nfix in muscle regeneration and muscular dystrophies RegeneratioNfix · 280611 | FP7 | €1,386,945 | €1,386,945 | Details |
Adolescent Precursors to Psychiatric Disorders – Learing from Analysis of User-Service Engagement APPLAUSE · 337673 | FP7 | €1,499,948 | €1,499,948 | Details |
Human leukemic stem cells: from identification towards targeting and eradication HULSCTARGETING · 281474 | FP7 | €1,499,820 | €1,499,820 | Details |
A POINT-OF-CARE BIOCHIP FOR HIV MONITORING IN THE DEVELOPING WORLD HIVBIOCHIP · 281166 | FP7 | €1,986,000 | €1,986,000 | Details |